drugset / Trial / NCT02174523

Pharmacokinetic Study of Lurasidone After Multiple Oral Administration in Healthy Human Subjects

NCT02174523

RandomizedParallel-groupTriple-blindOther

Summary

To evaluate the pharmacokinetic (PK) characteristics after multiple oral administration of 40 mg lurasidone in healthy Chinese subjects. To evaluate the safety and tolerance after multiple oral administration of 40 mg lurasidone in healthy Chinese subjects.

Timeline

Start
2014-04
Primary completion
2014-04
Completion
2014-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Lurasidone Small molecule 40 mg Oral

Indications